Defunct Company
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
896
NCT00219700
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2005
Completion: Nov 30, 2005
NCT04008979
Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex
Phase: Phase 1
Start: Feb 11, 2008
Completion: Jun 10, 2008
NCT00872534
Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers
Phase: Phase 1/2
Start: Jan 31, 2009
Completion: Jul 31, 2009
NCT00966641
Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults
Start: Aug 31, 2009
Completion: Oct 31, 2009
NCT01139190
Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults
Start: Jul 31, 2010
Completion: Dec 31, 2010
NCT01244100
Food-Effect Pharmacokinetic Study of PL2200
Start: Oct 31, 2010
Completion: Not specified
NCT01515657
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients
Phase: Phase 3
Start: Jan 31, 2012
Completion: Jun 30, 2012
NCT01646814
Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects
Start: Sep 30, 2012
Completion: Jun 30, 2013
NCT02008942
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients
Start: Jan 31, 2014
Completion: Apr 30, 2014
NCT05055752
Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers.
Start: May 7, 2020
Completion: Oct 1, 2020
NCT04811625
Pharmacodynamic and Pharmacokinetic Study of PL-ASA
Phase: Phase 4
Start: Apr 28, 2021
Completion: Sep 15, 2021